JPMorgan analyst Michael Mueller upgraded Healthcare Realty Trust to Overweight from Neutral with an unchanged price target of $19. The stock’s relative valuation could improve in the coming quarters as the legacy HTA portfolio occupancy gains materialize, the analyst tells investors in a research note. The firm believes Healthcare Realty’s underperformance has been driven by a combination of items including a slower than anticipated lease-up of the HTA assets earlier in the year and some earnings impact uncertainties tied to its large disposition program, “two items that are arguably in management’s control.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HR:
- Healthcare Realty Trust price target lowered to $17 from $19 at Scotiabank
- Healthcare Realty Trust price target lowered to $17 from $19 at Wells Fargo
- Healthcare Realty Trust price target lowered to $17 from $20 at BMO Capital
- Healthcare Realty Trust Publishes Investor Day Presentation and Provides Update on Asset Sales and New Leasing Momentum
- Seeking up to 8% Dividend Yield? Wedbush Suggests 2 Dividend Stocks to Buy
